HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.
about
Epithelial-mesenchymal transition in gastric cancerRole of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature reviewEGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells.Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation.Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition and analysis of their phosphorylation signaling pathwaysHigh expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma.Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.Epigenetics in gastric carcinogenesis: TET genes as important players.Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.The role of TWIST1 in epithelial-mesenchymal transition and cancers.MicroRNA-495 Inhibits Gastric Cancer Cell Migration and Invasion Possibly via Targeting High Mobility Group AT-Hook 2 (HMGA2).Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.VGLL4 inhibits EMT in part through suppressing Wnt/β-catenin signaling pathway in gastric cancer.Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer.Expression of HMGA2 in bladder cancer and its association with epithelial-to-mesenchymal transition.Expression and role of grainyhead-like 2 in gastric cancer.HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma.Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathway.Clinicopathological and prognostic significance of HMGA2 overexpression in gastric cancer: a meta-analysis.miR-367 stimulates Wnt cascade activation through degrading FBXW7 in NSCLC stem cells.High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis.Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors.Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.Prognostic Value of HMGA2 in Human Cancers: A Meta-Analysis Based on Literatures and TCGA Datasets.TiHo-0906: a new feline mammary cancer cell line with molecular, morphological, and immunocytological characteristics of epithelial to mesenchymal transition
P2860
Q26775029-9D42F653-260E-4976-B5D4-34BE89B24533Q28086989-A7285342-828C-482D-96C7-E1AE14F72666Q30384677-04B47603-D183-4B88-8710-7D2539045EBAQ35228755-B65C1C95-ABCB-41AA-A792-11E5B7731542Q37376276-A96A9C88-0737-4A48-A0C7-1C29D6EA49C3Q37469803-1E44AC1F-4798-481E-8FF9-C98A75A4CFCEQ37736423-C9310643-733B-427B-BC7B-87BEFB92F050Q38206587-1E103AAB-B0AC-44B0-B5DC-9577FF1964F7Q38365055-91C6F0E4-DA0F-49BD-8CCD-2AF201FF982DQ38604538-228888F6-9D79-4439-8783-C818294457ABQ38646345-E0A30372-8A35-4A40-98C1-93C88E50E139Q38718003-EA9F2B2D-2C85-4498-9DD9-8EDA8D442DC9Q38787288-DA374599-8B33-48FB-8250-95F5DCEC32FDQ38907612-7F7AB269-F0A9-4756-B5FC-877989F5643AQ38974180-E56A65D1-FAE8-4214-B6EE-5F045B8EB4F6Q39020752-E3646C08-28AA-42B1-9951-36B6FF4A2B50Q39091704-F7B89715-609D-4A6B-8A51-700FFAD3E14CQ41816648-9EEE1F48-1813-40FC-B9FC-6E223D36314DQ42055336-AE22953D-4373-4B94-9C70-3EF819757C67Q47097878-577FAE48-1CD1-424D-8A47-CDB897FD14B1Q47757966-78505839-B168-426F-947A-395B104DB4BCQ49288145-27528F32-6B95-4825-99AC-98853BDE5314Q52884225-0E6C15D9-0E6D-4BA7-B673-CF9A4C4D3327Q53238642-6EE388E3-D51C-4660-8DF7-E96406DBB650Q55710147-B7DA5671-042C-4353-B8EA-95518C01187FQ58763424-DA3DE3B7-0270-4C61-BAA8-0AC22E1F5BED
P2860
HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.
@en
HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.
@nl
type
label
HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.
@en
HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.
@nl
prefLabel
HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.
@en
HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.
@nl
P2093
P2860
P1476
HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.
@en
P2093
Jing Zhang
Neng Zhang
Weixue Tang
Ziwei Wang
P2860
P2888
P304
P356
10.1007/S10620-012-2399-6
P577
2012-11-08T00:00:00Z